Yazen Beddawi, MD
Critical Care (Intensivists) · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 4
- Since medical school
- 18 years
- Graduated 2008
Offices
4 locations · Inpatient Specialists of California PC · Hill Health Inc A Medical Corporation
Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Beddawi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A141961 · Current
Licensed to practise in California · since 2016 · expires 2028-01-31 · University of Damascus Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Critical Care Medicine
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Pulmonary Disease
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$86,950
Medicare paid this office $86,950 for 231 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 103 | $40,312 | $183 |
| Long return visit (40+ min) | 64 | $15,513 | $167 |
| New patient visit (60+ min) | 54 | $10,593 | $196 |
| Critical care, each additional 30 minutes | 19 | $4,053 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $3,859 | $104 |
See all 8 services
| Critical care, first 30-74 minutes | 103 | $40,312 | $183 |
| Long return visit (40+ min) | 64 | $15,513 | $167 |
| New patient visit (60+ min) | 54 | $10,593 | $196 |
| Critical care, each additional 30 minutes | 19 | $4,053 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $3,859 | $104 |
| Return visit (30+ min) | 15 | $1,978 | $124 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 19 | $1,057 | $53 |
| Exam of lung airways using an endoscope | 11 | $0 | $0 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 21 | 23 | 30 | 22 | – | – |
| Irrigation and suction of lung airways to obtain cells using an endoscope | – | 13 | 19 | 18 | 23 | 20 |
| Exam of lung airways using an endoscope | – | – | 14 | – | 21 | 12 |
| Emergent insertion of breathing tube into windpipe using an endoscope | – | – | 14 | 11 | – | – |
| Biopsy of lobe of lung using an endoscope, 1 lobe | – | – | – | – | 12 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
231 Original Medicare patients in 2024. Average age 75 · Under 65 9% · 85 and older 13% · Women 46% · Also on Medicaid 44% · Health risk score 2.45. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 2.58.
Conditions among them: High blood pressure 75% · Chronic kidney disease 52% · Heart failure 48% · COPD 48% · Diabetes 45% · Coronary heart disease 41% · Depression 37% · Atrial fibrillation 34% · Cancer 23% · Stroke 21% · Dementia 16%.
The office billed $543,607, Medicare allowed $109,988 and paid $86,950; for 572 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 231 | 572 | 75 | 2.45 | $543,607 | $86,950 |
| 2023 | 233 | 612 | 74 | 2.91 | $563,586 | $87,694 |
| 2022 | 234 | 760 | 74 | 2.47 | $835,897 | $111,450 |
| 2021 | 324 | 949 | 74 | 2.68 | $871,174 | $127,446 |
| 2020 | 300 | 800 | 73 | 2.99 | $194,777 | $102,015 |
| 2019 | 325 | 725 | 74 | 2.69 | $160,129 | $82,555 |
| 2018 | 335 | 724 | 72 | 2.65 | $176,713 | $93,949 |
| 2017 | 308 | 721 | 73 | 2.98 | $174,520 | $94,750 |
| 2016 | 109 | 257 | 73 | 2.41 | $64,741 | $34,713 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Critical care, first 30-74 minutes | 108 | $36,795 | $182 |
| Long return visit (40+ min) | 60 | $14,988 | $165 |
| New patient visit (60+ min) | 52 | $10,544 | $203 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $6,223 | $104 |
| Critical care, each additional 30 minutes | 32 | $5,479 | $93 |
| Return visit (30+ min) | 21 | $2,948 | $118 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,614 | $154 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 12 | $925 | $77 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 23 | $904 | $39 |
| Exam of lung airways using an endoscope | 21 | $9 | $0 |
2022: 10 services
| Critical care, first 30-74 minutes | 145 | $70,418 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $10,142 | $91 |
| Critical care, each additional 30 minutes | 49 | $7,213 | $95 |
| Long return visit (40+ min) | 22 | $5,350 | $167 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $4,099 | $114 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,662 | $174 |
| New patient visit (60+ min) | 13 | $2,270 | $175 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 22 | $1,597 | $73 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 11 | $1,328 | $121 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 17 | $1,078 | $60 |
2021: 11 services
| Critical care, first 30-74 minutes | 156 | $63,856 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 103 | $19,738 | $93 |
| Long return visit (40+ min) | 41 | $9,288 | $139 |
| Critical care, each additional 30 minutes | 62 | $8,879 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,562 | $180 |
| Return visit (30+ min) | 38 | $4,348 | $82 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 30 | $2,216 | $74 |
| New patient visit (60+ min) | 11 | $2,030 | $185 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 14 | $1,714 | $122 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 19 | $1,576 | $83 |
| Exam of lung airways using an endoscope | 14 | $136 | $10 |
2020: 11 services
| Critical care, first 30-74 minutes | 115 | $52,469 | $203 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 128 | $24,365 | $96 |
| Return visit (30+ min) | 41 | $5,569 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,879 | $180 |
| Critical care, each additional 30 minutes | 24 | $2,728 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,298 | $68 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,997 | $125 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 23 | $1,760 | $77 |
| New patient visit (45+ min) | 12 | $1,707 | $142 |
| Short return visit (20+ min) | 20 | $1,311 | $62 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 13 | $1,042 | $80 |
2019: 12 services
| Critical care, first 30-74 minutes | 122 | $39,962 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 104 | $17,476 | $92 |
| Return visit (30+ min) | 50 | $5,840 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,621 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $3,283 | $64 |
| Critical care, each additional 30 minutes | 20 | $2,617 | $97 |
| New patient visit (45+ min) | 14 | $2,111 | $151 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 21 | $1,559 | $74 |
| Short return visit (20+ min) | 18 | $967 | $54 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 18 | $210 | $12 |
| Test to determine lung volumes using sensors | 17 | $187 | $11 |
| Test to examine how well the lungs exchange gases | 17 | $138 | $8 |
2018: 13 services
| Critical care, first 30-74 minutes | 165 | $60,109 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $10,932 | $93 |
| Return visit (30+ min) | 43 | $4,726 | $96 |
| New patient visit (45+ min) | 25 | $3,733 | $149 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,903 | $121 |
| Critical care, each additional 30 minutes | 20 | $2,138 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,070 | $65 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 13 | $1,174 | $84 |
| Short return visit (20+ min) | 16 | $1,163 | $68 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 13 | $1,144 | $88 |
| Test to determine lung volumes using sensors | 17 | $165 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 15 | $163 | $11 |
| Test to examine how well the lungs exchange gases | 16 | $114 | $7 |
2017: 9 services
| Critical care, first 30-74 minutes | 168 | $64,420 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $11,047 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $4,615 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,345 | $117 |
| Critical care, each additional 30 minutes | 20 | $2,214 | $96 |
| Return visit (30+ min) | 15 | $1,475 | $98 |
| Test to determine lung volumes using sensors | 16 | $163 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 14 | $150 | $11 |
| Test to examine how well the lungs exchange gases | 18 | $136 | $8 |
2016: 3 services
| Critical care, first 30-74 minutes | 66 | $23,656 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $4,108 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,364 | $62 |
Medicaid work
$2,852 in 2024
Medicaid paid $2,852 for 34 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 34 | $2,852 |
| 2024 | 34 | 1 | 12 | $2,852 |
| 2023 | 64 | 1 | 18 | $5,245 |
| 2022 | 77 | 1 | 12 | $4,037 |
| 2021 | 75 | 2 | 15 | $3,369 |
| 2020 | 207 | 2 | 17 | $16,681 |
| 2019 | 48 | 1 | 15 | $5,295 |
| 2018 | 98 | 1 | 17 | $6,768 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 64 | $5,245 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 77 | $4,037 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 48 | $2,698 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 27 | $672 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 153 | $14,646 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 54 | $2,035 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 48 | $5,295 |
2018
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 98 | $6,768 |
Drugs they prescribed that Part D paid
$71,548
Pharmacies billed $71,548 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 278) in 2024. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 0%.
97 generic and 181 brand-name prescriptions · $71,548 in drug cost · 22 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 31 | $19,183 | $619 |
| Breo Ellipta | 34 | $15,306 | $450 |
| Spiriva Respimat | 11 | $7,272 | $661 |
| Symbicort | 17 | $3,753 | $221 |
| Breyna | 11 | $2,468 | $224 |
See all 7 drugs
| Trelegy Ellipta | 31 | $19,183 | $619 |
| Breo Ellipta | 34 | $15,306 | $450 |
| Spiriva Respimat | 11 | $7,272 | $661 |
| Symbicort | 17 | $3,753 | $221 |
| Breyna | 11 | $2,468 | $224 |
| Budesonide-Formoterol | 12 | $2,379 | $198 |
| Albuterol Sulfate Hfa | 52 | $1,753 | $34 |
Year by year
| 2024 | 278 | 82 | 0% (0) | 65% | $71,548 |
| 2023 | 223 | 73 | 0% (0) | 74% | $60,930 |
| 2022 | 140 | 38 | 0% (0) | 66% | $37,558 |
| 2021 | 127 | 36 | 0% (0) | 40% | $31,896 |
| 2020 | 50 | 20 | 0% (0) | 50% | $8,903 |
| 2019 | 45 | 17 | 0% (0) | 40% | $7,470 |
| 2018 | 60 | 22 | None | 55% | $11,587 |
| 2017 | 53 | 15 | None | 51% | $8,025 |
| 2016 | 69 | None | 0% (0) | 72% | $9,484 |
| 2015 | 78 | 20 | 0% (0) | 51% | $10,078 |
| 2014 | 109 | 15 | 0% (0) | 44% | $13,226 |
| 2013 | 66 | 17 | None | None | $4,365 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Breo Ellipta | 52 | $23,084 | $444 |
| Symbicort | 24 | $10,098 | $421 |
| Albuterol Sulfate Hfa | 49 | $1,799 | $37 |
| Ventolin Hfa | 12 | $737 | $61 |
2022: 3 drugs
| Breo Ellipta | 28 | $13,398 | $479 |
| Symbicort | 14 | $5,289 | $378 |
| Albuterol Sulfate Hfa | 32 | $1,583 | $49 |
2021: 4 drugs
| Symbicort | 11 | $3,977 | $362 |
| Albuterol Sulfate Hfa | 31 | $1,420 | $46 |
| Fluticasone Propionate | 19 | $389 | $20 |
| Omeprazole | 14 | $219 | $16 |
2019: 1 drug
| Fluticasone Propionate | 18 | $412 | $23 |
2018: 2 drugs
| Symbicort | 18 | $7,243 | $402 |
| Fluticasone Propionate | 13 | $236 | $18 |
2017: 1 drug
| Fluticasone Propionate | 11 | $150 | $14 |
2016: 1 drug
| Ventolin Hfa | 15 | $723 | $48 |
2015: 2 drugs
| Symbicort | 14 | $4,932 | $352 |
| Fluticasone Propionate | 11 | $204 | $19 |
2014: 4 drugs
| Spiriva | 18 | $6,811 | $378 |
| Proair Hfa | 12 | $673 | $56 |
| Azithromycin | 13 | $403 | $31 |
| Montelukast | 19 | $309 | $16 |
2013: 1 drug
| Chlorthalidone | 11 | $147 | $13 |
Money from drug and device companies
$359 in 2025
| 2025 | 3 | 5 | None | $359 |
| 2024 | 3 | 10 | None | $880 |
| 2021 | 1 | 1 | None | $12 |
| 2019 | 3 | 4 | None | $86 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Breztri | $253 | 2 payments
|
| Pulmonx | Chartis Catheter | $81 | 2 payments
|
| Genzyme | Dupixent | $25 | 1 payment
|
See all 5 published payments
| Pulmonx | Meals · 2025-12-29 | Chartis Catheter | $54 |
| Pulmonx | Meals · 2025-10-06 | Chartis Catheter | $27 |
| Genzyme | Meals · 2025-06-12 | Dupixent | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-09 | Breztri | $135 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-26 | None | $118 |
See earlier years (2024, 2021, 2019)
2024: $880
| Medtronic | Illumisite | $735 | 8 payments
|
| Boehringer Ingelheim Pharmaceuticals | None | $124 | 1 payment
|
| Genzyme | Dupixent | $21 | 1 payment
|
2021: $12
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $12 | 1 payment
|
2019: $86
| GlaxoSmithKline | Anoro | $37 | 2 payments
|
| Covidien LP | Superdimension | $25 | 1 payment
|
| Genzyme | Dupixent | $24 | 1 payment
|
Professional record
- NPI
- 1558594309
- Licence
- CA A141961, IN 11014762ACalifornia A141961: Current · expires 2028-01-31
- Group
- Inpatient Specialists of California PC · Hill Health Inc A Medical Corporation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Internal medicine (207R00000X); Federal specialty code 207RP1001X (207RP1001X); Student in a training program (390200000X)
- Mailing address
- 2450 Ashby Ave, Berkeley, CA, 94705
- NPI first listed
- 2009-08-27
- NPI last updated
- 2021-09-20
- NPI record certified
- 2021-09-20
This is when the NPI record was last certified, not a medical board exam.